• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.37 número1

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.37 número1"

Copied!
2
0
0

Texto

(1)

rev bras hematol hemoter. 2015;37(1):69–70

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

w w w . r b h h . o r g

Letter

to

the

Editor

To

follow

or

not

to

follow

the

recommendations

regarding

microscopic

analysis

of

the

Clinical

and

Laboratory

Standards

Institute

H20-A2

to

validate

the

criteria

for

blood

smear

review?

DearEditor,

WereadwithgreatinteresttheLettertotheEditorbyGrotto1

ontheneedtofollowtheClinicalandLaboratoryStandards Institute2007H20-A22guidelinesduringmicroscopic

analy-sisinreplytothestudybyComaretal.3 Weappreciatethe

commentsthatensuredextensivediscussiononthissubject. Thework ofBarnesetal.,4 whichrepresentsthecoreof

the criteriaforblood smear review(BSR)recommended by theInternational SocietyforLaboratoryHematology (ISLH), emanatesfromaninternationalconsensusamong20experts in 2002 during a conference in Indian Wells, CA, USA. In consensus,Barnesetal.4 proposedanine-stepprotocol for

validatingtheBSRcriteriainroutinelaboratorypractices.Step 4ofthisprotocolisasfollows:“Performaslidereviewofall samples.Limitthereviewstoonlyoneortwosenior tech-nologistsforconsistency.Manualdifferentialsshouldonlybe performedifthereisaspecificneedtodoso(e.g.,Voteout, abnormalcell-typeflags,etc.)”

Thestep-wiseprotocolbyBarnesetal.4doesnotmention

theNCCLSH20-A5asasinequanonconditionforthe

micro-scopicreviewofbloodsmears.Intheirwork,Barnesetal.4did

notmandatetheapplicationoftheNCCLSH20-A5guidelines,

asinterpretedbyGrotto.1Thus,Barnesetal.4didnotexclude

thepossibilityofoneobservercounting100cellstovalidate theBSRcriteria.Wethereforeunderstandthatcounting per-formedbyeitheroneortwoobserversisequallyacceptable.

TheCLSIH20-A22(formerlyNCCLSH20-A)5isareference

document to evaluate hematology analyzers that perform automated leukocyte differential counts and consider the visualleukocytedifferentialcountasthegoldstandard.Most studies that rigorously followed this guideline specifically evaluatedtheautomatedleukocytedifferentialcountandthe suspectflags ofthe hematology analyzers.6,7 On the other

hand,studiesevaluatingsetsofcriteriaforBSRdidnot nec-essarilyfollowtherecommendationsoftheNCCLSH20-A5or

CLSIH20-A22regardingthemicroscopicanalysis.4,8–11Thus,

weemphasizethat,inthestudyofComaretal.3thestep-wise

rulesofBarnesetal.4thatexclusivelydealwiththevalidation

oftheBSRcriteriawerefollowed.

WebelievethatBarnesetal.4recommendedslidereviewby

eitheroneortwoobservers,withoutspecifyingasetnumber ofslidespersamplenorthenumberofcellstobecountedper slide,toenableapplicationofthesameprotocolsofsample collectionandprocessingasinroutineprotocolsfor valida-tionpurpose,thussimulatingthereal-timeconditionsofmost hematologylaboratories.

WeevaluatedthecriteriaforBSRbyusingthehematology analyzersprovidedbySysmexCorporation.3Theapplication

of the criteriafor BSR adaptedfrom ISLHresulted in high falsenegative(FN)(>5%)andmicroscopicreviewrates(MRR). SimilarresultswerereportedbyXingetal.12inananalysis

of2400samplesusingtheADVIA120/2120hematology ana-lyzer,accordingtothescreeningcriteriaproposedbyISLHand theirown positivesmearfindings[FN=5.5%,falsepositives (FP)=28.1%,and MRR=50.2%]. Itisimportanttoemphasize that we did not conclude “the inadequate performanceof bothpiecesofequipment”inanyinstanceoftheproposals byComaretal.3Weexplainedthat30%oftheFPresults(i.e.,

6.98%ofthetotalsamplesor138samplesin1977)occurred duetothepresenceofsuspectflagsinthesamples.This per-centagerepresentsthesumofallsuspectflagsgeneratedin allsamplesandwhosemicroscopiccounterpartdidnot pro-videanypositivesmearfinding.WebelievethattheFPrates observedbyComaret al.3canbepartiallyattributedtothe

(2)

70

rev bras hematol hemoter. 2015;37(1):69–70

Inourexperience,inindividualanalysis,themainsuspect flagsdeliveredthefollowingresultsusingtheXE-2100D hema-tologyanalyzerforsamplessimilartothoseusedbyComar etal.3:TheFNrateandefficiencyforimmaturegranulocytes

were1.15%and94.71%;theFNrateforblastswas0.17%(n=3 samples);andtheefficiency,sensitivity,andspecificityforLeft Shiftwere82.4%,44%,and92.08%,respectively.13Therefore,

unlikeGrotto’s(1)interpretation,theperformancesofthese suspectflagswerealmostsimilartothosereportedby Stam-mingeretal.6andRuzickaetal.14

Insummary,eachlaboratoryshouldestablishitsown cri-teriaforBSRofbloodcountsaccordingtotheirpeculiarities, possibilities,andlimitations,anditshouldfollowthe appro-priateguidelinesandtoolstovalidatesuchcriteriainroutine laboratorypractices.Afteracarefulanalysisoftheresults dis-cussedabove,weconcludethattheuseoftherulesproposed byBarnesetal.4wasadequateinthestudyofComaretal.3

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1. GrottoHZ.Whyandhowvalidatethecriteriaformanual smearreviewforimprovingthelaboratoryproductivity?Rev BrasHematolHemoter.2014.thisissue.

2. ClinicalandLaboratoryStandardsInstitute(CLSI).Reference leukocyte(WBC)differentialcount(proportional)and evaluationofinstrumentmethods:approvedstandard.2nd ed.Wayne,PA:CLSI;2007.DocumentH20-A2.

3. ComarSR,MalvezziM,PasquiniR.Arethereviewcriteriafor automatedcompletebloodcountsoftheInternational SocietyofLaboratoryHematologysuitableforallhematology laboratories?RevBrasHematolHemoter.2014;36(3):219–25.

4. BarnesPW,McfaddenSL,MachinSJ,SimsonE.The internationalconsensusgroupforhematologyreview: suggestedcriteriaforactionfollowingautomatedCBCand WBCdifferentialanalysis.LabHematol.2005;11(2):83–90.

5. NationalCommitteeforClinicalLaboratoryStandards (NCCLS).Referenceleukocyte(WBC)differentialcount (proportional)andevaluationofinstrumentmethods: approvedstandard.Villanova,PA:NationalCommitteefor ClinicalLaboratoryStandards;1992.DocumentH20-A.

6. StammingerG,AuchD,DiemH,SinhaP.Performanceofthe XE-2100leukocytedifferential.ClinLabHaematol.

2002;24(5):271–80.

7.JonesRG,FaustA,GlazierJ,MatthewsR,PotterB.Cell-Dyn 4000:utilitywithinthecorelaboratorystructureand preliminarycomparisonofitsexpandeddifferentialwiththe 400-cellmanualdifferentialcount.LabHematol.1998;4:34–44.

8.ComarSR,MalvezziM,PasquiniR.Establishmentand evaluationofreviewcriteriaofautomatedcompleteblood countsapplyingreceiveroperatingcharacteristics(ROC) curveanalysis.IntJLabHematol.2013;35Suppl.1:44–5.

9.LantisKL,HarrisRJ,DavisG,RennerN,FinnWG.Elimination ofinstrument-drivenreflexmanualdifferentialleukocyte counts.Optimizationofmanualbloodsmearreviewcriteria inahigh-volumeautomatedhematologylaboratory.AmJ ClinPathol.2003;119(5):656–62.

10.PratumvinitB,WongkrajangP,ReesukumalK,KlinbuaC, NiamjoyP.Validationandoptimizationofcriteriaformanual smearreviewfollowingautomatedbloodcellanalysisina largeuniversityhospital.ArchPatholLabMed.

2013;137(3):408–14.

11.FroomP,HavisR,BarakM.Therateofmanualperipheral bloodsmearreviewsinoutpatients.ClinChemLabMed. 2009;47(11):1401–5.

12.XingY,WangJZ,PuCW,ShangK,YanZL,BaiWS,etal. EstablishmentandevaluationofreviewcriteriaforADVIA 120/2120anddifferentseriesofhematologyanalyzers. ZhonghuaYiXueZaZhi.2010;90(22):1526–30.

13.ComarSR,MalvezziM,PasquiniR.Theusefulnessofsuspect flagsontheSysmexXE-2100Dhematologyanalyzer.IntJLab Hematol.2014;36Suppl.1:110.

14.RuzickaK,VeitlM,Thalhammer-ScherrerR,SchwarzingerI. ThenewhematologyanalyserSysmexXE-2100Performance evaluationofanovelwhitebloodcelldifferentialtechnology. ArchPatholLabMed.2001;125(3):391–6.

SamuelRicardoComar∗,MariesterMalvezzi, Ricardo

Pasquini

UniversidadeFederaldoParaná(UFPR),Curitiba,PR,Brazil

Correspondingauthorat:LaboratóriodeHematologia,Unidade

deApoioDiagnóstico,HospitaldeClínicas,Universidade Fe-deraldoParaná(UFPR),RuaPadreCamargo,280,AltodaGlória, 80060-240Curitiba,PR,Brazil.

E-mailaddress:srcomar@ufpr.br(S.R.Comar).

Received19September2014 Accepted20September2014 Availableonline21November2014

http://dx.doi.org/10.1016/j.bjhh.2014.11.005

Referências

Documentos relacionados

adult patients diagnosed with myeloid leukemia from 1994 to 2011 in the Vale do Paraíba,.. State of

After the implementation of the neonatal screening test in Maranhão there was a significant reduction in the median age of hospitalized SCD patients, from 11.4 years in the

Few studies have reported the incidence of variant Philadelphia chromosomes or the breakpoints involved among Brazilian chronic myeloid leukemia patients.. Objective: The aim of

Objective: The aim of this study was to analyze the prognostic factors correlated with survival of patients with acute myeloid leukemia at the Hospital de Clínicas, Universidade

Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department. Clark OA, Lyman GH, Castro AA, Clark LG,

Age, gender, Durie–Salmon stage, history of autologous hematopoietic stem cell transplantation, and the distribution pattern and positivity of CD20 expression on multiple myeloma

Recent studies report that some variables affect the quality of the umbilical cord blood, especially those related to mater- nal and fetal features such as placental weight,

This study demonstrates that 18.6% of a representative sam- ple of community-dwelling elderly people from São José dos Campos, southeastern Brazil had mild anemia with the